RxDoctor Payments Data

Elaine Ho

Family · Albany, NYNPI 1134738040

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 27.9% of the total.

$1,570in general payments, 2019–2025

Across 86 payments — averaging $18.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$438
  • Novo Nordisk$176
  • GSK$153
  • Boehringer Ingelheim$121
  • Lilly USA, LLC$88
  • Indivior Inc.$75
  • plus $518 from 19 others

What the payments were for

  • Food & beverage$1,570100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,570 in reported general payments places this provider in the 80th percentile of 8,883 family providers in New York.

See all family providers in New York →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$259

Paid to pharmacies, not to this prescriber.

Other family in Albany

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →